封面
市場調查報告書
商品編碼
1618176

耳鼻喉科設備市場機會、成長動力、產業趨勢分析及 2024 年至 2032 年預測

ENT Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球耳鼻喉科設備市場價值 208 億美元,預計在整個預測期內複合年成長率為 6.3%。這種成長可歸因於多種因素,包括外科和診斷程序數量的增加、耳鼻喉疾病盛行率的顯著增加以及旨在提高對這些疾病認知的積極政府措施。市場擴張的關鍵驅動力之一是助聽器和人工耳蝸的日益認可和採用。隨著人口老化,聽力損失的發生率激增,導致對這些輔助設備的需求增加。

技術進步,例如配備藍牙連接和降噪功能的智慧助聽器的開發,進一步豐富了用戶體驗並刺激了該行業的成長。從產品類型來看,助聽器細分市場佔據了很大的市場佔有率,到2023 年將佔總佔有率的37.2%。尋求治療。此外,旨在提高助聽器普及率的政府政策和舉措,特別是在發展中地區,在促進市場成長方面發揮關鍵作用。就最終用戶而言,耳鼻喉設備市場分為醫院、門診手術中心、耳鼻喉診所和家庭護理。

2023 年,醫院領域以 36% 的佔有率主導市場,反映出耳鼻喉科診斷和手術設備在這些環境中的使用率不斷上升。最近的技術進步產生了精確有效的診斷工具,例如高清內視鏡和先進的成像系統。這些創新提高了診斷的準確性和治療計劃的有效性。耳鼻喉科疾病(包括慢性鼻竇炎、睡眠呼吸中止症和聽力損失)的發生率不斷上升,進一步推動了這些先進診斷和手術解決方案的需求。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 208億美元
預測值 360 億美元
複合年成長率 6.3%

在北美,耳鼻喉科設備市場將於 2023 年達到 81 億美元,預計在分析期間複合年成長率為 5.2%。該地區疾病患病率高、醫療基礎設施健全以及對技術創新的承諾推動了對耳鼻喉科設備的強勁需求。此外,人口老化和耳鼻喉科健康意識的提高也是促成因素。新產品的不斷批准和先進技術的引進也有望對市場成長產生積極影響。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 全球耳鼻喉科疾病盛行率不斷上升
      • 老年人口增加
      • 耳鼻喉科設備的技術進步
      • 對微創耳鼻喉手術的需求不斷成長
    • 產業陷阱與挑戰
      • 程序和儀器成本高
      • 全球各地的社會恥辱
  • 成長潛力分析
  • 報銷場景
    • 美國
    • 歐洲
  • 技術景觀
  • 監管環境
    • 美國
    • 歐洲
  • 未來市場趨勢
  • 價值鏈分析
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品類型,2021 - 2032 年

  • 主要趨勢
  • 耳鼻喉 (ENT) 診斷設備
    • 硬內視鏡
      • 鼻鏡
      • 喉鏡
      • 耳科內視鏡
    • 軟式內視鏡
    • 機器人輔助內視鏡
    • 聽力篩檢設備
  • 耳鼻喉 (ENT) 外科設備
    • 射頻手機
    • 動力手術器械
    • 耳科鑽頭
    • 耳鼻喉科手持器械
    • 鼓膜造口管
    • 鼻竇擴張裝置
    • 鼻腔填塞裝置
  • 助聽器
    • 耳背式 (BTE)
    • 完全在根管內/隱形在根管內 (CIC/IIC)
    • 運河內 [運河內 (ITC)]
    • 入耳式 (ITE)
    • 耳內接收器/耳道接收器 (RITE/RIC)
  • 聽力植入物
    • 聽覺腦幹植入物
    • 人工耳蝸
    • 中耳植入物
    • 骨錨式聽力系統
  • 發聲義肢裝置
  • 鼻夾板
    • 內鼻夾板
    • 鼻外夾板

第 6 章:市場估計與預測:依最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 耳鼻喉科診所
  • 居家護理

第 7 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 土耳其

第 8 章:公司簡介

  • Atos Medical
  • Boston Scientific Corporation
  • Cochlear
  • DeSoutter Medical
  • Johnson & Johnson
  • Lumenis
  • Medtronic
  • Meril Life Sciences
  • Narang Medical
  • Nouvag
  • Olympus Corporation
  • Smith & Nephew
  • Sonova Group
  • Stryker Corporation
  • Vega Medical
  • Welch Allyn
  • WestCMR
  • Zimmer Biomet
簡介目錄
Product Code: 496

The Global ENT Devices Market was worth USD 20.8 billion in 2023 and is projected to experience 6.3% CAGR throughout the forecast period. This growth can be attributed to several factors, including the rising number of surgical and diagnostic procedures, a significant increase in the prevalence of ENT disorders, and proactive government initiatives aimed at raising awareness about these conditions. One of the key drivers of market expansion is the growing recognition and uptake of hearing aids and cochlear implants. As populations age, the incidence of hearing loss has surged, resulting in heightened demand for these assistive devices.

Technological advancements, such as the development of smart hearing aids equipped with Bluetooth connection and noise-cancellation features, have further enriched the user experience and stimulated growth in this sector. Based on product type, the hearing aids segment represented a significant portion of the market, accounting for 37.2% of the total share in 2023. The increasing awareness of hearing loss's impact on overall quality of life is motivating more individuals to pursue treatment. Furthermore, government policies and initiatives designed to enhance access to hearing aids, particularly in developing regions, are playing a pivotal role in fostering market growth. In terms of end users, the ENT devices market is segmented into hospitals, ambulatory surgical centers, ENT clinics, and home care.

The hospital segment dominated the market with a share of 36% in 2023, reflecting the rising utilization of ENT diagnostic and surgical devices in these settings. Recent technological advancements have yielded precise and effective diagnostic tools, such as high-definition endoscopes and advanced imaging systems. These innovations have improved the accuracy of diagnoses and the efficacy of treatment planning. The growing incidence of ENT disorders, including chronic sinusitis, sleep apnea, and hearing loss, is further driving the demand for these advanced diagnostics and surgical solutions.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$20.8 Billion
Forecast Value$36 Billion
CAGR6.3%

In North America, the ENT devices market reached USD 8.1 billion in 2023 and is anticipated to grow at a CAGR of 5.2% over the analysis period. The strong demand for ENT devices in this region is fueled by a high prevalence of disorders, a robust healthcare infrastructure, and a commitment to technological innovation. Additionally, an aging population and heightened awareness regarding ENT health are contributing factors. The continuous approval of new products and the introduction of advanced technologies are also expected to positively influence market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of ENT disorders globally
      • 3.2.1.2 Increasing geriatric population
      • 3.2.1.3 Technological advancements in the ENT devices
      • 3.2.1.4 Rising demand for minimally invasive ENT procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High procedure and instruments cost
      • 3.2.2.2 Social stigma across the globe
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Technological landscape
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Future market trends
  • 3.8 Value-chain analysis
  • 3.9 Gap analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostic ear, nose, and throat (ENT) devices
    • 5.2.1 Rigid endoscopes
      • 5.2.1.1 Rhinoscopes
      • 5.2.1.2 Laryngoscopes
      • 5.2.1.3 Otological endoscopes
    • 5.2.2 Flexible endoscopes
    • 5.2.3 Robot assisted endoscopes
    • 5.2.4 Hearing screening devices
  • 5.3 Surgical ear, nose, and throat (ENT) devices
    • 5.3.1 Radiofrequency handpieces
    • 5.3.2 Powered surgical instruments
    • 5.3.3 Otological drill burrs
    • 5.3.4 ENT hand instruments
    • 5.3.5 Tympanostomy tubes
    • 5.3.6 Sinus dilation devices
    • 5.3.7 Nasal packing devices
  • 5.4 Hearing aids
    • 5.4.1 Behind-the-ear (BTE)
    • 5.4.2 Completely-in-the-canal/Invisible-in-canal (CIC/IIC)
    • 5.4.3 In-the-canal [In-the-canal (ITC)]
    • 5.4.4 In-the-ear (ITE)
    • 5.4.5 Receiver in the ear/Receiver in canal (RITE/RIC)
  • 5.5 Hearing implants
    • 5.5.1 Auditory brainstem implants
    • 5.5.2 Cochlear implants
    • 5.5.3 Middle ear implants
    • 5.5.4 Bone anchored hearing systems
  • 5.6 Voice prosthesis devices
  • 5.7 Nasal splints
    • 5.7.1 Internal nasal splints
    • 5.7.2 External nasal splints

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Ambulatory surgical centers
  • 6.4 ENT clinics
  • 6.5 Homecare

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Turkey

Chapter 8 Company Profiles

  • 8.1 Atos Medical
  • 8.2 Boston Scientific Corporation
  • 8.3 Cochlear
  • 8.4 DeSoutter Medical
  • 8.5 Johnson & Johnson
  • 8.6 Lumenis
  • 8.7 Medtronic
  • 8.8 Meril Life Sciences
  • 8.9 Narang Medical
  • 8.10 Nouvag
  • 8.11 Olympus Corporation
  • 8.12 Smith & Nephew
  • 8.13 Sonova Group
  • 8.14 Stryker Corporation
  • 8.15 Vega Medical
  • 8.16 Welch Allyn
  • 8.17 WestCMR
  • 8.18 Zimmer Biomet